A58 Stock Overview
Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States.
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 1/6 |
| Past Performance | 3/6 |
| Financial Health | 5/6 |
| Dividends | 4/6 |
Elevance Health, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$494.70 |
| 52 Week High | US$498.50 |
| 52 Week Low | US$370.00 |
| Beta | 0.81 |
| 1 Month Change | 5.71% |
| 3 Month Change | 12.43% |
| 1 Year Change | 17.79% |
| 3 Year Change | 58.00% |
| 5 Year Change | 111.95% |
| Change since IPO | 428.13% |
Recent News & Updates
Recent updates
Shareholder Returns
| A58 | DE Healthcare | DE Market | |
|---|---|---|---|
| 7D | 3.9% | 2.7% | 0.5% |
| 1Y | 17.8% | -1.8% | 1.3% |
Return vs Industry: A58 exceeded the German Healthcare industry which returned 0.6% over the past year.
Return vs Market: A58 exceeded the German Market which returned 2.3% over the past year.
Price Volatility
| A58 volatility | |
|---|---|
| A58 Average Weekly Movement | 2.9% |
| Healthcare Industry Average Movement | 6.1% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.2% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: A58 has not had significant price volatility in the past 3 months.
Volatility Over Time: A58's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2001 | 104,900 | Gail Boudreaux | www.elevancehealth.com |
Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. The company operates through four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to program members; health products; an array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, life, disability, and supplemental health insurance benefits.
Elevance Health, Inc. Fundamentals Summary
| A58 fundamental statistics | |
|---|---|
| Market cap | €115.64b |
| Earnings (TTM) | €5.82b |
| Revenue (TTM) | €160.10b |
20.1x
P/E Ratio0.7x
P/S RatioIs A58 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A58 income statement (TTM) | |
|---|---|
| Revenue | US$171.75b |
| Cost of Revenue | US$124.09b |
| Gross Profit | US$47.66b |
| Other Expenses | US$41.41b |
| Earnings | US$6.24b |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 26.87 |
| Gross Margin | 27.75% |
| Net Profit Margin | 3.64% |
| Debt/Equity Ratio | 65.0% |
How did A58 perform over the long term?
See historical performance and comparisonDividends
1.2%
Current Dividend Yield23%
Payout RatioDoes A58 pay a reliable dividends?
See A58 dividend history and benchmarks| Elevance Health dividend dates | |
|---|---|
| Ex Dividend Date | Jun 10 2024 |
| Dividend Pay Date | Jun 25 2024 |
| Days until Ex dividend | 45 days |
| Days until Dividend pay date | 60 days |
Does A58 pay a reliable dividends?
See A58 dividend history and benchmarks